Cortney Scheiner

Founded in 1939, Scotia Capital, Inc. is a full-service financial services firm headquartered in Toronto, Ontario. The firm is a subsidiary of the Bank of Nova Scotia (NYSE: BNS) Their global operations are divided into two primary business units: (1) global corporate and investment banking and (2) global capital markets.

Greengreen Capital Corp. is a private company based in Thornhill, Canada.

Cancer Care Ontario operates as an Ontario government’s principal cancer advisor. It engages in conducting clinical involvement, strategic planning, analytics and informatics, strong government and relationship programs. The company was founded in and is headquartered in

Provect Technologies, Inc. develops and installs employee management systems. It provides employee scheduling and time management systems. The firm's products enable organizations to track labor data and manager resources in real-time. The company was founded in 2002 and is headquartered in Oak Park, IL.

Public Health Ontario provides healthcare services. The non-profit company is based in Toronto, Canada. The Canadian company was founded by Vivek Goel.

The Association of Public Health Epidemiologists in Ontario (APHEO) is an organization that aims to advance and promote the discipline and professional practice of public health epidemiology in Ontario. The organization is based in Ontario, Canada. The Canadian company has a new strategic plan available on their website and hold an annual conference where presentations are available to members. APHEO also has a core indicators project strategic plan available for download.

The Integrated Public Health Information System provides database services for public health units. The private company is based in Toronto, Canada.

Transmed7 LLC is a medical and technology-based organization that focuses on developing innovative, minimally-invasive medical devices for doctors and their patients. The private company is based in Phoenix, AZ. The company's portfolio of next-generation platform devices is expected to be market leaders in oncology, regenerative medicine, and cardiovascular disease. Transmed7's business plan and structure enable these new transformational technologies to move from rapid development through commercial manufacturing and market deployment. The company's transformational forward-coring, zero5 biopsy devices improve patient care with broad applications to breast, soft tissue, endoscopy, laparoscopy, robotics, vascular, bone marrow, and more. The company was founded in 2010 by Eugene H. Vetter, James W. Vetter. Eugene H. Vetter has been the CEO since 2010.